ATE550020T1 - Verbindungen zur selektiven behandlung der intestinalen, immunologisch bedingten komponente von zöliakie - Google Patents

Verbindungen zur selektiven behandlung der intestinalen, immunologisch bedingten komponente von zöliakie

Info

Publication number: ATE550020T1
Authority: AT; Austria
Prior art keywords: celiac disease; compounds; selective treatment; immunological component; treatment
Prior art date: 2007-12-24

Application number

AT08863709T

Other languages

English (en)

Inventor

Sergio Baroni

Salvatore Bellinvia

Original Assignee

Giuliani Int Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-12-24

Filing date

2008-12-23

Publication date

2012-04-15

2008-12-23 Application filed by Giuliani Int Ltd filed Critical Giuliani Int Ltd

2012-04-15 Application granted granted Critical

2012-04-15 Publication of ATE550020T1 publication Critical patent/ATE550020T1/de

Links

208000015943 Coeliac disease Diseases 0.000 title abstract 4
150000001875 compounds Chemical class 0.000 title abstract 3
230000001900 immune effect Effects 0.000 title 1
230000000968 intestinal effect Effects 0.000 title 1
235000005911 diet Nutrition 0.000 abstract 2
WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 abstract 1
102000004127 Cytokines Human genes 0.000 abstract 1
108090000695 Cytokines Proteins 0.000 abstract 1
230000000903 blocking effect Effects 0.000 abstract 1
230000037213 diet Effects 0.000 abstract 1
230000000378 dietary effect Effects 0.000 abstract 1
230000002757 inflammatory effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/606—Salicylic acid; Derivatives thereof having amino groups
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Furan Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT08863709T 2007-12-24 2008-12-23 Verbindungen zur selektiven behandlung der intestinalen, immunologisch bedingten komponente von zöliakie ATE550020T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT002429A ITMI20072429A1 (it)	2007-12-24	2007-12-24	Composti per il trattamento selettivo della componente immuno-infiammatoria intestinale della malattia celiaca
PCT/EP2008/068265 WO2009080828A2 (en)	2007-12-24	2008-12-23	Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease

Publications (1)

Publication Number	Publication Date
ATE550020T1 true ATE550020T1 (de)	2012-04-15

Family

ID=40315657

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT08863709T ATE550020T1 (de)	2007-12-24	2008-12-23	Verbindungen zur selektiven behandlung der intestinalen, immunologisch bedingten komponente von zöliakie

Country Status (23)

Country	Link
US (2)	US8153693B2 (de)
EP (2)	EP2279733A3 (de)
JP (1)	JP2011507818A (de)
KR (1)	KR20100103836A (de)
CN (2)	CN101969943A (de)
AT (1)	ATE550020T1 (de)
AU (1)	AU2008339909A1 (de)
BR (1)	BRPI0821331A2 (de)
CA (1)	CA2708512A1 (de)
CY (1)	CY1112821T1 (de)
DK (1)	DK2222291T3 (de)
EA (1)	EA201001058A1 (de)
ES (1)	ES2384361T3 (de)
HR (1)	HRP20120404T1 (de)
IL (1)	IL206226A0 (de)
IT (1)	ITMI20072429A1 (de)
MX (1)	MX2010007033A (de)
NZ (1)	NZ586191A (de)
PL (1)	PL2222291T3 (de)
PT (1)	PT2222291E (de)
SI (1)	SI2222291T1 (de)
WO (1)	WO2009080828A2 (de)
ZA (1)	ZA201004802B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2359812C (en)	2000-11-20	2004-02-10	The Procter & Gamble Company	Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
ITRM20050390A1 (it)	2005-07-22	2007-01-23	Giuliani Spa	Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
ITRM20050389A1 (it)	2005-07-22	2007-01-23	Giuliani Spa	Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
UA107562C2 (uk) *	2008-12-05	2015-01-26		Спосіб лікування псоріазу
WO2010091894A2 (en)	2009-02-16	2010-08-19	Giuliani International Limited	Methods of treating hair related conditions
CN103153944A (zh) *	2010-09-10	2013-06-12	法莫再尔公司	晶态5-氨基水杨酸的制备方法
CN109999017A (zh)	2012-02-09	2019-07-12	诺格拉制药有限公司	治疗纤维化的方法
CN104284655B (zh)	2012-04-18	2017-10-27	诺格拉制药有限公司	治疗乳糖不耐受的方法
WO2019164874A1 (en) *	2018-02-20	2019-08-29	Western New England University	Thiol isomerases inhibitors for the treatment and prevention of food allergies, allergic diseases, and inflammatory diseases
EP4495101A3 (de)	2019-02-08	2025-04-30	Nogra Pharma Limited	Verfahren zur herstellung von 3-(4'-aminophenyl)-2-methoxypropionsaure, sowie analoge uno zwischenprodukte davon
CN113801126A (zh) *	2021-07-20	2021-12-17	云南大学	一种多取代吡啶衍生物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1313697T3 (da) *	2000-08-29	2006-04-10	Nobex Corp	Immunregulatoriske forbindelser, derivater deraf samt anvendelse deraf
AU2004314731B2 (en)	2004-01-20	2011-07-07	The Board Of Regents Of The University Of Oklahoma	Compositions and methods of treatment for inflammatory diseases
US20060270635A1 (en) *	2005-05-27	2006-11-30	Wallace John L	Derivatives of 4- or 5-aminosalicylic acid
WO2006125293A1 (en) *	2005-05-27	2006-11-30	Antibe Therapeutics Inc.	Derivatives of 4- or 5-aminosalicylic acid
ITRM20050390A1 (it)	2005-07-22	2007-01-23	Giuliani Spa	Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
ITRM20050389A1 (it) *	2005-07-22	2007-01-23	Giuliani Spa	Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.

2007
- 2007-12-24 IT IT002429A patent/ITMI20072429A1/it unknown
2008
- 2008-12-23 SI SI200830659T patent/SI2222291T1/sl unknown
- 2008-12-23 CN CN2008801225541A patent/CN101969943A/zh active Pending
- 2008-12-23 HR HRP20120404AT patent/HRP20120404T1/hr unknown
- 2008-12-23 NZ NZ586191A patent/NZ586191A/en not_active IP Right Cessation
- 2008-12-23 EP EP10188940A patent/EP2279733A3/de not_active Withdrawn
- 2008-12-23 CA CA2708512A patent/CA2708512A1/en not_active Abandoned
- 2008-12-23 JP JP2010538801A patent/JP2011507818A/ja active Pending
- 2008-12-23 ES ES08863709T patent/ES2384361T3/es active Active
- 2008-12-23 AT AT08863709T patent/ATE550020T1/de active
- 2008-12-23 EA EA201001058A patent/EA201001058A1/ru unknown
- 2008-12-23 EP EP08863709A patent/EP2222291B1/de not_active Not-in-force
- 2008-12-23 KR KR1020107016082A patent/KR20100103836A/ko not_active Withdrawn
- 2008-12-23 PL PL08863709T patent/PL2222291T3/pl unknown
- 2008-12-23 BR BRPI0821331-3A patent/BRPI0821331A2/pt not_active IP Right Cessation
- 2008-12-23 US US12/810,159 patent/US8153693B2/en not_active Expired - Fee Related
- 2008-12-23 CN CN2011103980277A patent/CN102641279A/zh active Pending
- 2008-12-23 DK DK08863709.5T patent/DK2222291T3/da active
- 2008-12-23 MX MX2010007033A patent/MX2010007033A/es active IP Right Grant
- 2008-12-23 PT PT08863709T patent/PT2222291E/pt unknown
- 2008-12-23 AU AU2008339909A patent/AU2008339909A1/en not_active Abandoned
- 2008-12-23 WO PCT/EP2008/068265 patent/WO2009080828A2/en not_active Ceased
2010
- 2010-06-07 IL IL206226A patent/IL206226A0/en unknown
- 2010-07-07 ZA ZA2010/04802A patent/ZA201004802B/en unknown
2011
- 2011-12-20 US US13/331,173 patent/US20120157417A1/en not_active Abandoned
2012
- 2012-06-06 CY CY20121100511T patent/CY1112821T1/el unknown

Also Published As

Publication number	Publication date
EP2279733A2 (de)	2011-02-02
IL206226A0 (en)	2010-12-30
JP2011507818A (ja)	2011-03-10
US8153693B2 (en)	2012-04-10
WO2009080828A3 (en)	2009-10-01
DK2222291T3 (da)	2012-06-25
HRP20120404T1 (hr)	2012-06-30
US20100305077A1 (en)	2010-12-02
BRPI0821331A2 (pt)	2015-06-16
US20120157417A1 (en)	2012-06-21
EP2222291A2 (de)	2010-09-01
EA201001058A1 (ru)	2011-02-28
CN102641279A (zh)	2012-08-22
SI2222291T1 (sl)	2012-08-31
CA2708512A1 (en)	2009-07-02
ZA201004802B (en)	2011-03-30
AU2008339909A1 (en)	2009-07-02
EP2279733A3 (de)	2011-03-23
CN101969943A (zh)	2011-02-09
KR20100103836A (ko)	2010-09-28
PL2222291T3 (pl)	2012-08-31
ES2384361T3 (es)	2012-07-04
ITMI20072429A1 (it)	2009-06-25
NZ586191A (en)	2012-06-29
PT2222291E (pt)	2012-07-02
WO2009080828A2 (en)	2009-07-02
EP2222291B1 (de)	2012-03-21
MX2010007033A (es)	2010-10-07
CY1112821T1 (el)	2016-02-10

Similar Documents

Publication	Publication Date	Title
ATE550020T1 (de)	2012-04-15	Verbindungen zur selektiven behandlung der intestinalen, immunologisch bedingten komponente von zöliakie
NL301089I2 (nl)	2021-02-04	imlifidase
CY1119746T1 (el)	2018-06-27	Φαρμακευτικες μορφοποιησεις που περιεχουν ριφαξιμινη, διαδικασιες για τη ληψη τους και μεθοδος αγωγης εντερικων νοσων
EA201270184A1 (ru)	2012-08-30	Лечение расстройств печени ингибиторами pi3k
NO20073790L (no)	2007-09-03	Kjemiske forbindelser
NO20073788L (no)	2007-09-03	Kjemiske forbindelser
TN2009000291A1 (en)	2010-12-31	Inhibitors of mek
NO20070049L (no)	2007-01-30	Pyrrolotriazinderivater anvendelig for behandling av hyperproliferative forstyrrelser og sykdommer assosiert med angiogenese
NO20081636L (no)	2008-05-29	FAP - inhibitorer
EA201390609A1 (ru)	2014-01-30	ПРОИЗВОДНЫЕ ГИДАНТОИНА, ПОЛЕЗНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ Kv3-КАНАЛОВ
UA89812C2 (ru)	2010-03-10	Замещенные пиридинильные и пиримидинильные производные, которые применяют как модуляторы метаболизма и для лечения ассоциированных с ним расстройств
NO20084374L (no)	2008-11-05	Imidazoltiazolforbindelser for behandling av sykdom
CY1108077T1 (el)	2014-02-12	Αρυλο-υποκατεστημενες πολυκυκλικες αμινες, μεθοδος για την παρασκευη τους και η χρηση τους ως φαρμακων
CR9347A (es)	2007-12-17	Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos
MX2007004276A (es)	2007-05-16	1,5-naftiridin-azolidinonas que tienen actividad antiproliferativa de cdk-1.
EA200971068A1 (ru)	2010-04-30	Триазолиламинопиримидиновые соединения
EA201170425A1 (ru)	2011-10-31	Тетрациклиновые соединения для лечения ревматоидного артрита и связанные с ними способы лечения
CY1115604T1 (el)	2017-01-04	Μακροκυκλικα παραγωγα ουριας και σουλφαμιδης ως αναστολεις των ταfια
EA201001835A1 (ru)	2011-06-30	Противовирусные соли
BRPI0811557A2 (pt)	2019-09-24	composto, composição farmacêutica, método de tratamento ou profilaxia de uma condição inflamatória.
EA200801120A1 (ru)	2008-08-29	Нафтильные производные в качестве ингибиторов агрегирования бета-амилоида
EA200800342A1 (ru)	2008-08-29	ИНГИБИТОРЫ Glepp-1 ДЛЯ ЛЕЧЕНИЯ АУТОИММУННЫХ И/ИЛИ ВОСПАЛИТЕЛЬНЫХ РАССТРОЙСТВ
RU2006138371A (ru)	2008-05-10	Способ лечения послеоперационного пареза кишечника
EA202090507A1 (ru)	2020-07-27	Активаторы пируваткиназы для применения в лечении нарушений со стороны крови
ATE505195T1 (de)	2011-04-15	Acylglycerophospholipide zur behandlung von krebs-begleiterscheinungen